Provention bio to present at the virtual h.c. wainwright bioconnect conference

Red bank, n.j., jan. 6, 2022 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will present at the h.c.
PRVB Ratings Summary
PRVB Quant Ranking